ClinicalTrials.gg
Active, not recruitingNCT03300713MOCITRAININGUpdated May 22, 2026

MOther-Child Interaction Assessment TRAINING for Pediatricians

An interventional study of MOCITRAINING program and usual follow-up in Child Behavior Disorders, Mother-child Relations and Depression, Postpartum, sponsored by University Hospital, Lille. Active, not recruiting at 1 site in France. Open to participants aged 23 Days to 37 Days. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by University Hospital, Lille · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
3,504
Allocation
Randomized
Ages
23 Days to 37 Days
Sex
All
01

Study summary

The originality of the MOCITRAINING study lies in the integration of infant and maternal care during the pediatric consultation and the assessment of the impact of this type of care in the short and medium term on The MOCITRAINING program could contribute to improving the quality of parent-child interactions.

02

Conditions studied

  • Child Behavior Disorders
  • Mother-child Relations
  • Depression, Postpartum

Keywords

  • Mass screening
  • Pediatrician training
03

In context

Child Behavior Disorders

35 studies on the registry are indexed under Child Behavior Disorders; 10 are open to participants now.

This study's planned enrollment of 3,504 is above the median of 134 across 25 interventional studies indexed under Child Behavior Disorders.

Browse Child Behavior Disorders studies →

Lead sponsor

University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
23 Days to 37 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Each child will be included WITH his biological mother at the first-month visit after birth.
  • Age: 1 month + / - 15 days (child), accompanied by his biological mother
  • Mother able to read French;
  • Signed consent letter after complete information of parents about the MOCITRAINING study, its principle, advantages and disadvantages.

Exclusion criteria

Exclusion Criteria:

  • Preterm babies.
  • Children from a twin or multiple pregnancy.
  • Children with somatic diagnosis explaining the presence of digestive, sleeping or interactional disorders.
  • Refusal to participate after clear information about the study;
  • Refusal to sign the consent letter;
  • Refusal to be informed of a diagnostic hypothesis;
  • Participants not covered by the Social Security system;
  • Participants incapable of consenting or under legal protection (guardianship or curatorship).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,504 participants (estimated)

Study arms

  • Experimental
    F+ group (Mocitraining program)

    including 8 pediatricians' clusters. F+ pediatricians will attend a specific training focused on mother-child interactions, maternal psychiatric disorders, particularly PND screening and early interventions for non-psychiatric physician.

    Other: MOCITRAINING program

  • Sham comparator
    F- group (usual follow-up)

    grouping 8 pediatricians' clusters. They will not receive the initial training on early interactional disorders and PND screening

    Other: usual follow-up

Interventions

  • OtherMOCITRAINING program

    The program is clinical and psychometric tools for screening for interactions and postpartum psychiatric disorders. The program will expose the existing care arrangements and the different possible orientations of the families according to the identified problem.

  • Otherusual follow-up

    usual follow-up

06

What researchers measure

Primary outcomes

  1. Frequency of pathological Alarm Distress BaBy (ADBB) scores

    Time frame: in 12-month-aged children.

Secondary outcomes

  1. Frequency of pathological Alarm Distress BaBy (ADBB) scores

    Time frame: in 4, 9 and 24 month-aged children

  2. Frequency of digestive disorders

    presence/absence of infantile regurgitations and colics

    Time frame: in 4, 9, 12 and 24 month-aged children

  3. Number of daytime sleep hours

    Time frame: in 4, 9, 12 and 24 month-aged children

  4. Number of nighttime awakenings

    Time frame: in 4, 9, 12 and 24 month-aged children

  5. Scores on maternal self-evaluation scales (Likert scales)

    Scores on maternal self-evaluation scales (Likert scales) about parent-child relations (Items concerning comfort and pleasure during interactions)

    Time frame: at 12 and 24 months postpartum

  6. Frequency of dyads referred for psychiatric or perinatal psychiatric consultations

    Time frame: in 4, 9, 12 and 24 month-aged children

  7. Frequency of maternal psychotropic medication

    Time frame: in 4, 9, 12 and 24 month-aged children

07

Study locations

1 site
  • CHU
    Lille, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03300713
Collaborators
Ministry of Health, France
Responsible party
Sponsor
First posted
Oct 3, 2017
Start date
Dec 2, 2017
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 22, 2026

Study contacts

Renaud Jardri, MD, PhD
principal investigator · University Hospital, Lille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion